Publications by authors named "Stephen R Mattarollo"

41Publications

NKT Cell-Driven Enhancement of Antitumor Immunity Induced by Clec9a-Targeted Tailorable Nanoemulsion.

Cancer Immunol Res 2019 06 3;7(6):952-962. Epub 2019 May 3.

The University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://cancerimmunolres.aacrjournals.org/lookup/doi/10.1158/
Publisher Site
http://dx.doi.org/10.1158/2326-6066.CIR-18-0650DOI Listing
June 2019

Interaction of neurotransmitters and neurochemicals with lymphocytes.

J Neuroimmunol 2019 07 11;332:99-111. Epub 2019 Apr 11.

The University of Queensland Centre for Clinical Research, Royal Brisbane and Women's Hospital, Brisbane, Australia; Royal Brisbane and Women's Hospital, Herston, Brisbane, Australia. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01655728193008
Publisher Site
http://dx.doi.org/10.1016/j.jneuroim.2019.04.006DOI Listing
July 2019

Recruitment of Antigen Presenting Cells to Skin Draining Lymph Node From HPV16E7-Expressing Skin Requires E7-Rb Interaction.

Front Immunol 2018 18;9:2896. Epub 2018 Dec 18.

Translational Research Institute, The University of Queensland Diamantina Institute, Brisbane, QLD, Australia.

View Article

Download full-text PDF

Source
https://www.frontiersin.org/article/10.3389/fimmu.2018.02896
Publisher Site
http://dx.doi.org/10.3389/fimmu.2018.02896DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305623PMC
November 2019

The prognostic significance of circulating tumor cells in head and neck and non-small-cell lung cancer.

Cancer Med 2018 12 22;7(12):5910-5919. Epub 2018 Nov 22.

The School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.1832DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308060PMC
December 2018

Therapeutic vaccination with 4-1BB co-stimulation eradicates mouse acute myeloid leukemia.

Oncoimmunology 2018 26;7(10):e1486952. Epub 2018 Jul 26.

The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, Queensland, Australia.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/2162402X.2018.1
Publisher Site
http://dx.doi.org/10.1080/2162402X.2018.1486952DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169580PMC
July 2018

B cell lymphoma progression promotes the accumulation of circulating Ly6Clo monocytes with immunosuppressive activity.

Oncoimmunology 2018 18;7(2):e1393599. Epub 2017 Dec 18.

The University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2017.1393599DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749670PMC
December 2017

HPV16E7-Induced Hyperplasia Promotes CXCL9/10 Expression and Induces CXCR3 T-Cell Migration to Skin.

J Invest Dermatol 2018 06 23;138(6):1348-1359. Epub 2017 Dec 23.

The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2017.12.021DOI Listing
June 2018

Natural killer cell metabolism.

Mol Immunol 2019 11 24;115:3-11. Epub 2017 Nov 24.

The University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane 4102, Queensland, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molimm.2017.11.021DOI Listing
November 2019

β-Adrenergic Signaling Impairs Antitumor CD8 T-cell Responses to B-cell Lymphoma Immunotherapy.

Cancer Immunol Res 2018 01 16;6(1):98-109. Epub 2017 Nov 16.

The University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-17-0401DOI Listing
January 2018

Invariant Natural Killer T Cells in Immune Regulation of Blood Cancers: Harnessing Their Potential in Immunotherapies.

Front Immunol 2017 23;8:1355. Epub 2017 Oct 23.

The University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, QLD, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2017.01355DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660073PMC
October 2017

Therapeutic Efficacy of 4-1BB Costimulation Is Abrogated by PD-1 Blockade in a Model of Spontaneous B-cell Lymphoma.

Cancer Immunol Res 2017 03 23;5(3):191-197. Epub 2017 Jan 23.

The University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-16-0249DOI Listing
March 2017

Control of B-cell lymphoma by therapeutic vaccination and acquisition of immune resistance is independent of direct tumour IFN-gamma signalling.

Immunol Cell Biol 2016 07 20;94(6):554-62. Epub 2016 Jan 20.

The University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/icb.2016.9DOI Listing
July 2016

NKT cell-targeted vaccination plus anti-4-1BB antibody generates persistent CD8 T cell immunity against B cell lymphoma.

Oncoimmunology 2015 Mar 7;4(3):e990793. Epub 2015 Jan 7.

The University of Queensland Diamantina Institute; The University of Queensland; Translational Research Institute, Brisbane ; Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/2162402X.2014.990793DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404843PMC
March 2015

Interleukin-17A Promotes Arginase-1 Production and 2,4-Dinitrochlorobenzene-Induced Acute Hyperinflammation in Human Papillomavirus E7 Oncoprotein-Expressing Skin.

J Innate Immun 2015 14;7(4):392-404. Epub 2015 Feb 14.

The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Qld., Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000374115DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738793PMC
March 2016

IL-17 suppresses immune effector functions in human papillomavirus-associated epithelial hyperplasia.

J Immunol 2014 Sep 25;193(5):2248-57. Epub 2014 Jul 25.

University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Queensland 4102, Australia; and Australian Infectious Diseases Research Centre, University of Queensland, Brisbane, Queensland 4102, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1400216DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4135400PMC
September 2014

Immunosuppressive roles of natural killer T (NKT) cells in the skin.

J Leukoc Biol 2014 Jul 5;96(1):49-54. Epub 2014 May 5.

The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba, Brisbane, Queensland, Australia

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1189/jlb.4RU0114-001RDOI Listing
July 2014

IL-18, but not IL-12, induces production of IFN-γ in the immunosuppressive environment of HPV16 E7 transgenic hyperplastic skin.

J Invest Dermatol 2014 Oct 22;134(10):2562-2569. Epub 2014 Apr 22.

The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jid.2014.201DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165718PMC
October 2014

Combining low-dose or metronomic chemotherapy with anticancer vaccines: A therapeutic opportunity for lymphomas.

Oncoimmunology 2013 Dec 5;2(12):e27058. Epub 2013 Nov 5.

The University of Queensland Diamantina Institute; The University of Queensland; Translational Research Institute; Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.27058DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902116PMC
December 2013

CCL2/CCR2-dependent recruitment of functional antigen-presenting cells into tumors upon chemotherapy.

Cancer Res 2014 Jan 3;74(2):436-45. Epub 2013 Dec 3.

Authors' Affiliations: INSERM, U848; Institut Gustave Roussy; INSERM, U1015, CBT1017; Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, Villejuif, France; Université Paris Descartes/Paris V, Sorbonne Paris Cité; Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris; Université Paris Sud/Paris XI; Le Kremlin Bicêtre; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP; Paris; INSERM, UMR 996, LabEx LERMIT, Clamart, France; Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria; Diamantina Institute; School of Medicine, University of Queensland; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia; Laboratorio de Vetores Virais, Instituto do Coração, FM-USP, São Paulo, Brazil; and Genomics & Immunoregulation, LIMES-Institute, University of Bonn, Bonn, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-13-1265DOI Listing
January 2014

An intact immune system is required for the anticancer activities of histone deacetylase inhibitors.

Cancer Res 2013 Dec 24;73(24):7265-76. Epub 2013 Oct 24.

Authors' Affiliations: Cancer Therapeutics Program, and Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria; The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba; Queensland Institute of Medical Research; and School of Medicine, University of Queensland, Herston, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-13-0890DOI Listing
December 2013

NKT cell adjuvants in therapeutic vaccines against hematological cancers.

Oncoimmunology 2013 Jan;2(1):e22615

Cancer Immunology Program; Peter MacCallum Cancer Centre; East Melbourne, Victoria, Australia ; The University of Queensland Diamantina Institute; Princess Alexandra Hospital; Woolloongabba, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.22615DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583928PMC
January 2013

Expression of a single, viral oncoprotein in skin epithelium is sufficient to recruit lymphocytes.

PLoS One 2013 26;8(2):e57798. Epub 2013 Feb 26.

The University of Queensland Diamantina Institute, University of Queensland, Princess Alexandra Hospital, Woolloongabba, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0057798PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582605PMC
August 2013

Transient Foxp3(+) regulatory T-cell depletion enhances therapeutic anticancer vaccination targeting the immune-stimulatory properties of NKT cells.

Immunol Cell Biol 2013 Jan 23;91(1):105-14. Epub 2012 Oct 23.

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/icb.2012.58DOI Listing
January 2013

Role of γδ T cells in α-galactosylceramide-mediated immunity.

J Immunol 2012 Apr 12;188(8):3928-39. Epub 2012 Mar 12.

Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1103582DOI Listing
April 2012

γδ T cells augment rejection of skin grafts by enhancing cross-priming of CD8 T cells to skin-derived antigen.

J Invest Dermatol 2012 Jun 23;132(6):1656-64. Epub 2012 Feb 23.

The University of Queensland Diamantina Institute, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S0022202X1535782
Publisher Site
http://dx.doi.org/10.1038/jid.2012.16DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352982PMC
June 2012

NKT cells inhibit antigen-specific effector CD8 T cell induction to skin viral proteins.

J Immunol 2011 Aug 8;187(4):1601-8. Epub 2011 Jul 8.

University of Queensland Diamantina Institute, Princess Alexandra Hospital, Woolloongabba, Queensland 4102, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1100756DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3150369PMC
August 2011

Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors.

Cancer Res 2011 Jul 6;71(14):4809-20. Epub 2011 Jun 6.

Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-11-0753DOI Listing
July 2011

Regulation of immune responses to HPV infection and during HPV-directed immunotherapy.

Immunol Rev 2011 Jan;239(1):85-98

The University of Queensland Diamantina Institute, Princess Alexandra Hospital, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-065X.2010.00966.xDOI Listing
January 2011

Prevention and treatment of papillomavirus-related cancers through immunization.

Annu Rev Immunol 2011 ;29:111-38

The University of Queensland Diamantina Institute, Princess Alexandra Hospital, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1146/annurev-immunol-031210-101308DOI Listing
June 2011

A novel axis of innate immunity in cancer.

Nat Immunol 2010 Nov;11(11):981-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ni1110-981DOI Listing
November 2010

Secretion of IFN-gamma but not IL-17 by CD1d-restricted NKT cells enhances rejection of skin grafts expressing epithelial cell-derived antigen.

J Immunol 2010 May 21;184(10):5663-9. Epub 2010 Apr 21.

The University of Queensland Diamantina Institute for Cancer, Immunology, and Metabolic Medicine, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.

View Article

Download full-text PDF

Source
http://www.jimmunol.org/cgi/doi/10.4049/jimmunol.0903730
Publisher Site
http://dx.doi.org/10.4049/jimmunol.0903730DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921625PMC
May 2010

Invariant NKT cells in hyperplastic skin induce a local immune suppressive environment by IFN-gamma production.

J Immunol 2010 Feb 18;184(3):1242-50. Epub 2009 Dec 18.

The University of Queensland Diamantina Institute, Immunology and Metabolic Medicine, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.0902191DOI Listing
February 2010

Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity.

Cancer Immunol Immunother 2007 Aug 31;56(8):1285-97. Epub 2007 Jan 31.

Centre for Immune and Targeted Therapy, University of Queensland, Brisbane, QLD, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-007-0279-2DOI Listing
August 2007

Chemotherapy pretreatment sensitizes solid tumor-derived cell lines to V alpha 24+ NKT cell-mediated cytotoxicity.

Int J Cancer 2006 Oct;119(7):1630-7

Centre for Immune and Targeted Therapy, University of Queensland, Greenslopes Private Hospital, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.22019DOI Listing
October 2006